In conclusion, GB treatment protected from CPZ-induced behavior abnormalities, inhibited the inflammatory response, and promoted myelin generation in CPZ demyelinating model, implicating that GB might act as a novel strategy for the treatment of MS in clinic. Here, CPZ is linked to myeloid sarcoma.